For significant weight loss, Zepbound may be the better option. If you have Type 2 diabetes and are looking for a dual ...

According to the Ozempic prescribing information, you should stop taking Ozempic at least two months before a planned ...

Ozempic maker Novo Nordisk (NVO) announced mixed results today for a phase 2 trial of an experimental weight loss pill that ...

Semaglutide injections effectively support weight loss by regulating appetite and glucose levels, offering benefits for ...

Lilly and Novo Nordisk, the maker of Ozempic and Wegovy, have been under pressure to lower ... McGowan said most patients in ...

Novo Nordisk presented data on its next-generation weight-loss candidate, amycretin, which showed a significant 13% weight ...

Eli Lilly's long-term growth prospects are strong with improved supply, new growth opportunities, and competitive positioning ...

A recent study suggests that people taking the GLP-1 liraglutide experienced more bone loss than people who exercised during ...

Lilly also sells tirzepatide under the brand name Mounjaro, to treat people with diabetes, though they typically lose less weight than people without the disease. The list price of both Mounjaro and ...

Novo Nordisk A/S's shares have stalled recently, but this looks like a natural digestion of gains from prior years. Click for ...

Taking a high dose of ADHD drugs is linked to more than five times greater risk of developing psychosis or mania, according to a new study published Thursday in the American Journal of Psychiatry.

Terns Pharmaceuticals Inc.’s stock soared 30% early Monday, after the company said an early-stage trial of its obesity treatment in pill form achieved statistically significant weight loss of up to 5.